[Efficacity of chlorhydrate of tropatepine on Parkinsonian symptomatology].
Study of the action of tropatepine in 25 cases of Parkinson's disease and 5 post-neuroleptic syndromes. Good improvement in 70% of the cases, with disparition of tremor and reduction of akinesia. Fair tolerance when the posology is slowly progressive and when the posology remains moderate (less than 10 mg).
D000328:Adult; D000368:Aged; D003988:Dibenzothiepins / Q000494:pharmacology* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D014202:Tremor / Q000188:drug therapy
D003988:Dibenzothiepins; C013322:tropatepine
Etude de l'efficacité du chlorhydrate de tropatépine sur la symptomatologie parkinsonienne.